baber/WOPTO huggingface dataset:
Patent CA-2745492-A1 (CA)
Title: A polyclonal or monoclonal antibody or antibody binding fragment that binds to a tmem154 polypeptide
Inventor: LEVINE ZURIT
IPC: C07K14/705
Filed: 2009-12-08
Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KRTCAP3, FAM26F, MGC52498, FAM70A or TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages. This invention further relates to extracellular domains of KRTC AP3, FAM26F, MGC52498, FAM70A and TMEM154 proteins and variants, and therapeutic usages thereof.
Patent CA-2746764-A1 (CA)
Inventor: LIU YUGANG
IPC: A61P29/00
Filed: 2009-12-17
Abstract: This invention relates to a novel crystalline form (Form A) of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzy-loxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this crystalline form, to processes for forming it and to its use in medical treatment.
Patent CA-2746791-A1 (CA)
Title: Emballage pour stores et procede de coupe de couvre-fenetres
Inventor: CLUETT TIMOTHY D
IPC: B23D23/00
Filed: 2011-07-18
Abstract: Un emballage pour un couvre-fenêtre aux dimensions en magasin comprend une boîte comportant une première partie s'étendant sur toute la largeur du couvre-fenêtre et une deuxième partie s'étendant sur moins que la largeur de ce dernier. Le couvre-fenêtre s'étend au-delà d'une extrémité d'un mur inférieur sur une première distance et le rail supérieur s'étend au-delà d'une extrémité d'un premier mur latéral sur une seconde distance. Un procédé visant à couper un couvre-fenêtre comprend la fourniture d'un couvre-fenêtre dans une boîte tel que décrit ci-dessus et à positionner la boîte avec la partie exposée du couvre-fenêtre orientée vers le bas et la partie exposée du rail supérieur orientée vers une pince. Des procédés d'emballage d'un couvre-fenêtre comprennent la réduction du nombre total de boucles dans le couvre-fenêtre et à positionner les inserts entre les composants adjacents.
Patent CA-2747357-A1 (CA)
Inventor: MORIN JEAN-XAVIER
IPC: C10J3/84
Filed: 2009-12-16
Abstract: L'invention concerne un procédéde production et de purification d'un gaz de synthèse au moyen d'un combustible carboné, consistant à effectuer une gazéification dans un premier réacteur (1A) à une température comprise entre 780 et 1150°C et à effectuer une purification du gaz obtenu dans un deuxième réacteur (2A). Selon l'invention, -ladite gazéification est effectuée au moyen d'une première boucle de réacteur à lit fluidisé rapide (1) comportant ledit premier réacteur (1A) alimenté en oxydant, un premier séparateur cyclone associé (1B) et une première conduite de retour des solides (1C) vers ledit premier réacteur (1A), -ladite purification est effectuée au moyen d'une unique deuxième boucle de réacteur à lit fluidisé rapide (2) comportant ledit deuxième réacteur (2A) fluidisé par le gaz obtenu en sortie de gaz dudit premier séparateur cyclone (1B), un deuxième séparateur cyclone associé (2B) et une deuxième conduite de retour des solides (2C) vers ledit deuxième réacteur(2A), ledit deuxièmeréacteur (2A) fonctionnant à une température d'environ600°C en partie basse et à une température d'environ 400°C en partie haute.
Patent CA-2747789-A1 (CA)
Inventor: CHUN SUNG-DUCK
IPC: H04W74/08
Filed: 2010-01-06
Abstract: Disclosed is the radio (wireless) communication system providing a radio communication service and the terminal, and more particularly, a method of handling time alignment command during a random access procedure in an Evolved Universal Mobile Telecommunications System (E-UMTS) evolved from the Universal Mobile Telecommunications System (UMTS) or a Long Term Evolution (LTE) system is provided.
Patent CA-2748476-A1 (CA)
Inventor: MCMASTER WILLIAM J
IPC: F24C15/04
Filed: 2011-08-04
Abstract: An oven door includes an interior panel and an exterior panel. The interior panel faces the heating chamber and has a glass sheet for viewing the heating chamber. The exterior panel is affixed to the interior panel and includes a frame portion formed of plastic defining an aperture aligned with the glass sheet for viewing the heating chamber. A non-opaque panel is fixed relative to the frame portion and extends across the aperture.  The non-opaque panel has an inside surface facing the interior panel and the exterior panel has a masking portion formed of plastic and integrally formed with the frame portion. The masking portion extends from the frame portion into the aperture along the inside surface of the non-opaque panel and defines a window for viewing the heating chamber through the glass sheet.
Patent CA-2750789-A1 (CA)
Inventor: GINDRAT MALKO
IPC: H01J37/32
Filed: 2010-01-15
Abstract: A plasma coating plant for coating or treating the surface of a substrate (3) is proposed, having a work chamber (2) which can be evacuated and into which the substrate (3) can be placed, and having a plasma torch (4) for generating a plasma jet (5) by heating a process gas, wherein the plasma torch (4) has a nozzle (41) through which the plasma jet (5) can exit the plasma torch (4) and can extend along a longitudinal axis (A) into the work chamber (2), wherein a mechanical limiting apparatus (12) is provided downstream of the nozzle (41) in the work chamber (2), which mechanical limiting apparatus extends along the longitudinal axis (A) and protects the plasma jet (5) against an unwanted lateral intrusion of particles. A corresponding method is also proposed.
Patent CA-2751442-A1 (CA)
Title: Low dose single step grating based x-ray phase contrast imaging
Inventor: ZHU PEIPING
IPC: A61B6/00
Filed: 2010-02-03
Abstract: Phase sensitive X-ray imaging methods can provide substantially increased contrast over conventional absorption based imaging, and therefore new and otherwise inaccessible information. The use of gratings as optical elements in hard X-ray phase imaging overcomes some of the problems that have impaired the wider use of phase contrast in X-ray radiography and tomography.  So far, to separate the phase information from other contributions detected with a grating interferometer, a phase-step-ping approach has been considered, which implies the acquisition of multiple radiographic projections. Here, an innovative, high-ly sensitive X-ray tomographic phase contrast imaging approach is presented based on grating interferometry, which extracts the phase contrast signal without the need of phase stepping. Compared to the existing phase step approach, the main advantage of this new method dubbed "reverse projection" is the significantly reduced delivered dose, without degradation of the image quality.  The new technique sets the pre-requisites for future fast and low dose phase contrast imaging methods, fundamental for imaging biological specimens and in-vivo studies.
Patent CA-2754374-A1 (CA)
Title: Affichage transparent pour electromenagers
Inventor: BUSALT GERHARD
IPC: F24C15/00
Filed: 2011-10-04
Abstract: Un appareil électroménager comprend une surface avant ayant une apparence. Un affichage transparent disposé sur la surface avant présente une apparence correspondant à celle de parties de la surface avant de lappareil électroménager qui sont adjacentes à laffichage. Laffichage peut être disposé (p. ex., monté) sur lextérieur de la surface avant de manière que celle-ci soit visible à travers laffichage transparent. Laffichage transparent peut également être disposé dans ou derrière une ouverture dans la surface avant de lappareil électroménager. Dans le cas présent, une plaque de finition dont lapparence sharmonise à la surface avant de lappareil ménager est montée derrière laffichage transparent et la plaque de finition est visible à travers ce dernier.
Patent CA-2759541-A1 (CA)
Inventor: BRAVO CORDERO MARCELO LEONARDO
IPC: A61K9/00
Filed: 2010-04-23
Abstract: The present invention provides a delivery system for active and functional ingredients. In particular, the delivery systems of the present invention find particular application in the delivery of active and functional ingredients, such as medica-ments, pharmaceuticals, nutritional supplements, botanicals, cosmeceuticals etc.  Further, the invention relates to a delivery system for oral or topical administration of such active and functional ingredients.  The invention is a delivery system based on a particu-late gel precursor that acts both as the bodying agent,as well as the dispersing and suspending agent in the formulation. By modi-fying the level of precursor and process conditions, a broad range of product consistencies can be achieved ranging from thin liq-uid suspension to firm or semi solid gel. The precursor gel is a particulate linear chain fuctan gel. Inulin is a preferred fructan.
Patent CA-2760027-A1 (CA)
Title: Mass spectrometry using laserspray ionization
Inventor: TRIMPIN SARAH
IPC: H01J27/24
Filed: 2010-06-03
Abstract: Disclosed herein are systems and methods for mass spectrometry using laserspray ionization (LSI). LSI can create multiply-charged ions at atmospheric pressure for analysis and allows for analysis of high molecular weight molecules including molecules over 4000 Daltons. The analysis can be solvent-based or solvent-free. Solvent-free analysis following LSI allows for improved spatial resolution beneficial in surface and/or tissue imaging.
Patent CA-2762057-A1 (CA)
Title: Compliant balloon catheter
Inventor: MIHALIK TERESA ANN
IPC: A61B18/02
Filed: 2006-04-17
Abstract: A catheter (34) includes a first expandable membrane (62) having a first pressurization limit and a second expandable membrane (64), having a second pressurization limit, wherein the second pressurization limit is greater than the first pressurization limit, the first expandable membrane defines a cooling chamber, the second expandable membrane being disposed around the first expandable membrane to define an junction (57) therebetween. The catheter includes a coolant injection lumen in fluid communication with the at least one fluid inlet port and the cooling chamber, and a primary coolant return lumen in fluid communication with the at least one fluid outlet port and the cooling chamber. The coolant injection tube, the cooling chamber, and the primary coolant return lumen define a first fluid pathway. The catheter further includes a secondary coolant return lumen in fluid communication with the at least one fluid outlet port and the junction. The junction and the secondary coolant return lumen define a second fluid pathway. The catheter provides a fail-safe feature by selecting the appropriate first and second pressurization limits for the first and second expandable membranes.
Patent CA-2763270-A1 (CA)
Inventor: SARNOFF NORTON
IPC: A47J45/06
Filed: 2012-01-06
Abstract: In summary there is provided in one embodiment a pan having a bottom base having a base periphery edge, a sidewall extending upwardly from the base periphery edge and terminating at a side edge to create a well therebetween, an outwardly extending ridge being an extension from the sidewall edge, the ridge having at least two opposing portions extending from the sidewall at a length to define a pair of opposing handles, a circular rim extending along the periphery of the ridge, and, at least one pair of gripping members separately positioned in each handle, the gripping members being defined to include an indentation with a lowered section extending below a lower surface defined by the periphery of the ridge, such that the lowered section is visible from a side of the pan.
Patent CA-2768502-A1 (CA)
Title: Sugarcane centromere sequences and minichromosomes
Inventor: PREUSS DAPHNE
IPC: C13B5/00
Filed: 2010-07-23
Abstract: The invention is generally related to Sugarcane mini-chromosomes and recombinant chromosomes containing Sugarcane centromere sequences. In addition, the invention provides for methods of generating Sugarcane plants transformed with these Sugarcane mini-chromosomes. Sugarcane mini-chromosomes with novel compositions and structures are used to transform Sugarcane cells which are in turn used to generate Sugarcane plants. Methods for generating Sugarcane plants include methods for delivering the Sugarcane mini-chromosomes into Sugarcane cell to transform the cell, methods for selecting the transformed cell, and methods for isolating Sugarcane plants transformed with the Sugarcane mini-chromosome or recombinant chromosome.
Patent CA-2769406-A1 (CA)
Title: Lung cancer biomarkers
Inventor: GUERGOVA-KURAS MARIANA
IPC: C07K16/30
Filed: 2010-08-04
Abstract: The present invention relates to compositions and methods for detecting, managing or monitoring cancer. The invention also relates to antibodies specific for cancer markers, compositions and chips containing the same, as well as their uses for cancer detection, managing, monitoring, imaging or treatment, as well as for drug development. The invention is particularly suited for detecting, managing or monitoring lung cancer in human subjects.
Patent CA-2770200-A1 (CA)
Inventor: CAMPBELL CURTIS BAY
IPC: C11B9/02
Filed: 2010-08-20
Abstract: The present invention is directed to an enhanced oil recovery composition comprising (a) a surfactant comprising an alkylated hydroxyaromatic sulfonate having formula (I), wherein R1 is an alkyl group containing from about 8 to 40 carbon atoms and having from about 20 % to about 50 % methyl branching, and M is a mono-valent cation; (b) a solvent; (c) a passivator; and (d) a polymer.
Patent CA-2770270-A1 (CA)
Inventor: SIVAN URI
IPC: G01N27/447
Filed: 2010-08-18
Abstract: A device for isoelectric focusing. The device comprises a focusing container configured to contain an electrolyte solution and having a longitudinal axis and at least one electrolysis unit mounted in a close proximity to the longitudinal axis. Each electrolysis unit injects an ion flow into the focusing container so as to create a pH gradient having a plurality of steps in the electrolyte solution, along the longitudinal axis. Each step has a substantially uniform pH level and the pH gradient is defined by at least one pH ramp between every two sequential steps of the plurality of steps.
Patent CA-2774546-A1 (CA)
Inventor: CHENEY JUSTIN LEE
IPC: B23K9/04
Filed: 2010-09-17
Abstract: Existing weld overlay materials typically suffer from cracking during welding processes as well as poor toughness. Materials of the present disclosure may be used as a superior weld overlay material, such as for the protection of tool joints in oil and gas drilling operations or other overlay hardfacing applications. Disclosed herein are iron-based alloys having a microstructure comprising a fine-grained ferritic matrix and having a 60+  Rockwell C surface, wherein the ferrific matrix comprises <10 µm Nb and W  carbide precipitates. Also disclosed are methods of welding comprising forming a crack free hardbanding weld overlay coating with such an iron-based alloy. Also disclosed are methods of designing an alloy capable of forming a crack free hardbanding weld overlay.  An exemplary iron-based alloy composition may comprise constituents as provided in wt % below. Fe65.3-79.95Cr3-7Ni0-6Mn0-6Nb3.5-7V0-2.05C0.5-1.5B0.6-1.75W8.5-15.45Si0-1.0Ti0-1Al0-4
Patent CA-2775755-A1 (CA)
Inventor: HILL MICHAEL T
IPC: A62B7/10
Filed: 2010-09-30
Abstract: Breathing apparatuses which utilize active scrubbing in a closed loop system providing for scrubbing of air on exhalation, but inhalation to be from a clean air source without the air from that source passing back through an active filter immediately prior to inhalation.  The systems and methods may also use endothermic reactions from repressurization of make-up air to cool the clean air source providing further comfort.
Patent CA-2779105-A1 (CA)
Title: Kinase inhibitors
Inventor: KIM HONG WOO
IPC: A61K31/519
Filed: 2010-10-29
Abstract: The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.
Patent CA-2779262-A1 (CA)
Title: Engineered microorganisms capable of converting pyruvate to isobutanol under anaerobic conditions
Inventor: BUELTER THOMAS
IPC: C12P7/02
Filed: 2009-11-02
Abstract: The present invention is generally provides recombinant microorganisms comprising engineered metabolic pathways capable of producing C3-05 alcohols under aerobic and anaerobic conditions.                                     The invention further provides ketol-acid reductoisomerase enzymes which have been mutated or modified to increase their NADH-dependent activity or to switch the cofactor preference from NADPH to NADH and are expressed in the modified microorganisms. In addition, the invention provides isobutyraldehyde dehydrogenase enzymes expressed in modified microorganisms.     Also provided are methods of producing beneficial metabolites under aerobic and anaerobic conditions by contacting a suitable substrate with the modified microorganisms of the present invention.
Patent CA-2780678-A1 (CA)
Inventor: KAHRE OLEV
IPC: C12N9/00
Filed: 2010-11-19
Abstract: This disclosure provides peptides, polypeptides, fusion polypeptides, compositions, and methods for enhancing or increasing the stability of a polypeptide (e.g., Taq polymerase). Such peptides, polypeptides, fusion polypeptides, or compositions include polypeptides linked to a peptide tag that enhances the stability of the polypeptide. The peptides, polypeptides, fusion polypeptides, compositions may also enhance the activity, specificity, and/or fidelity of other polypeptides in a reaction mixture. The disclosure also provides methods of using such peptides, polypeptides, fusion polypeptides, compositions.
Patent CA-2783221-A1 (CA)
Inventor: KRUK MARIE
IPC: A61H39/00
Filed: 2012-07-13
Abstract: A patient seeking complementary and alternative medicine (CAM) must visit a practitioner which is not always convenient or possible. It would be beneficial to provide a patient with a simple means of deriving benefit from such physical CAM techniques in a non-intimidating manner whereby the means has familiarity associated with it. Even with conventional medicine children, infants, toddlers, and babies require medical treatment and experience fear and / or anxiety arising from visiting the medical practitioner or with the treatment. According to embodiments of the invention provide patients are provided means to exploit CAM techniques away from the practitioner or allow patients to not associate activities with a medical treatment but another activity, such as playing in the instance of a child. Variations of the means allow medical monitoring activities to be similarly associated with familiar objects and non-traumatic activities.
Patent CA-2787793-A1 (CA)
Title: Emulsified antiperspirant composition and method for making same
Inventor: SWAILE DAVID FREDERICK
IPC: A61K8/92
Filed: 2008-06-18
Abstract: Antiperspirant compositions that include a continuous phase employing a water- immiscible liquid and a structurant, the water-immiscible liquid has a flash point above about 80°C. The antiperspirant compositions further include a disperse phase employing a solution of antiperspirant active in water.
Patent CA-2788725-A1 (CA)
Inventor: KASAHARA NAOKO
IPC: C09D7/62
Filed: 2011-02-03
Abstract: Disclosed is an aqueous primer composition which contains (A) an aqueous dispersion of a modified polyolefin, (B) an aqueous urethane resin and/or an aqueous acrylic resin, (C) a pyrazole blocked polyisocyanate compound and (D) a conductive pigment. The content ratio of the pyrazole blocked polyisocyanate compound (C) is within the range of 5-50% by mass relative to the total solid content of the component (A), the component (B) and the component (C). The conductive pigment (D) contains (D-1) a conductive metal oxide, and the content of the conductive pigment (D) is within the range of 50-200 parts by mass per 100 parts by mass of the total resin solid content in the composition. Also disclosed is a method for coating a plastic molded article, which uses the composition.
Patent CA-2789238-A1 (CA)
Title: Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening
Inventor: GARFIELD ROBERT
IPC: A61K39/00
Filed: 2011-03-09
Abstract: The invention relates to methods and pharmaceutical compositions for inhibiting or preventing preterm birth, inhibiting or delaying cervical ripening, inhibiting myometrial contractility and treating or inhibiting uterine contractility disorders. The methods comprise administering an effective amount of a composition comprising steroid hormones such as soluble progesterone.
Patent CA-2789388-A1 (CA)
Title: A temperature differential engine device
Inventor: LIU ANGFENG
IPC: F03G7/04
Filed: 2011-02-09
Abstract: A temperature differential engine device includes a low-boiling-point medium steam turbine (1), a heat absorber (2), a thermal-insulating type low-temperature countercurrent heat exchanger (3), a circulating pump (4), and a refrigerating system (5) which are interconnected to constitute a closed circulating system filled with low-boiling-point medium fluid. The low-boiling-point medium steam turbine (1) and the heat absorber (2) constitute a low-density-medium heat-absorbing working system, and the circulating pump (4) and the refrigerating system (5) constitute a high-density-medium refrigerating-circulating system. The temperature differential engine device can transfer thermal energy into mechanical energy.
Patent CA-2790649-A1 (CA)
Inventor: WABNIK STEFAN
IPC: G10L19/00
Filed: 2011-02-22
Abstract: A watermark generator (2400) for providing a watermark signal (2420) in dependence on binary message data (2410) comprises an information processor (2430) configured to provide, in dependence on a single message bit of the binary message data, a 2-dimensional spread information (2432) representing the message bit in the form of a set of time-frequency-domain values. The watermark generator also comprises a watermark signal provider (2440) configured to provide the watermark signal on the basis of the 2-dimensional spread information. A Watermark detector, methods and computer programs are also described.
Patent CA-2790758-A1 (CA)
Inventor: DILLON PATRICK
IPC: H04M1/57
Filed: 2012-09-25
Abstract: The present disclosure relates to emergency services and more particularly, to a temporary callback system for emergency calls and methods thereof. In one illustrative embodiment, the system can include a private branch exchange (PBX) or other processing device having a pool of callback identities. When an emergency call is made, a callback identity can be temporarily assigned to the device making the call. The callback identity can provide insurance that the call is maintained. If the call between the device and answering point becomes abandoned or disconnected, the callback identity can be used to re-establish the connection. The callback identity can be released when cleared by the answering point or when a time limit expires. After being released, the callback identity can be made available to other devices that wish to make emergency calls.